Network meta-analysis (NMA) to support regulatory submissions for innovative psoriatic arthritis therapy
Our client developed an innovative therapy for psoriatic arthritis. They required a comprehensive efficacy comparison of their product with all existing therapies for an FDA submission. The client who had had issues with their first phase of the NMA and was seeking an expert team to conduct a high quality NMA to support their submission.
Download the case study to see how we developed a rigorous NMA that allowed our client to compare the efficacy of their product against all possible competitors.